Skip to content
naulon

Not checkedNot checked for notices yet.

Moving Beyond Tools and Building Bridges: Lessons Learned From a CKD Decision Support in Primary Care

Priya Joshi, Sankar D. Navaneethan, Michelle M. Estrella

Kidney Medicine · 2022

doi:10.1016/j.xkme.2022.100497 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Related Article, 100493 Related Article, 100493 The gaps in chronic kidney disease (CKD) detection and treatment have stubbornly remained wide.1Tummalapalli S.L. Powe N.R. Keyhani S. Trends in quality of care for patients with CKD in the United States.Clin J Am Soc Nephrol. 2019; 14: 1142-1150Crossref PubMed Scopus (22) Google Scholar In addition to very low awareness of CKD among affected patients,2Tuot D.S. Plantinga L.C. Hsu C.Y. et al.Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction.Clin J Am Soc Nephrol. 2011; 6: 1838-1844Crossref PubMed Scopus (101) Google Scholar primary care providers have cited multilevel barriers that impede the management of CKD and the coordination of CKD care with nephrologists and other specialists.3Sperati C.J. Soman S. Agrawal V. et al.Primary care physicians’ perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study.PLoS One. 2019; 14e0221325Crossref PubMed Scopus (22) Google Scholar,4Greer R.C. Liu Y. Cavanaugh K. et al.Primary care physicians’ perceived barriers to nephrology referral and co-management of patients with CKD: a qualitative study.J Gen Intern Med. 2019; 34: 1228-1235Crossref PubMed Scopus (24) Google Scholar Provider-level barriers include difficulty in assimilating CKD guidelines with those for other concurrent chronic conditions (eg, diabetes and blood pressure guidelines), whereas system-level barriers include limited time, a lack of standardized quality metrics, and difficulty in obtaining timely nephrology referrals.3Sperati C.J. Soman S. Agrawal V. et al.Primary care physicians’ perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study.PLoS One. 2019; 14e0221325Crossref PubMed Scopus (22) Google Scholar Primary care providers have long advocated for decision support tools and team-based care that are integrated into their clinical workflow.3Sperati C.J. Soman S. Agrawal V. et al.Primary care physicians’ perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study.PLoS One. 2019; 14e0221325Crossref PubMed Scopus (22) Google Scholar,4Greer R.C. Liu Y. Cavanaugh K. et al.Primary care physicians’ perceived barriers to nephrology referral and co-management of patients with CKD: a qualitative study.J Gen Intern Med. 2019; 34: 1228-1235Crossref PubMed Scopus (24) Google Scholar One component of such tools that has been proposed is the Kidney Failure Risk Equation (KFRE). The KFRE accurately discriminates the risk of progression to kidney failure, defined by the initiation of dialysis or kidney transplantation, across diverse populations5Tangri N. Grams M.E. Levey A.S. et al.Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis.JAMA. 2016; 315: 164-174Crossref PubMed Scopus (273) Google Scholar,6Tangri N. Stevens L.A. Griffith J. et al.A predictive model for progression of chronic kidney disease to kidney failure.JAMA. 2011; 305: 1553-1559Crossref PubMed Scopus (666) Google Scholar and can, thus, identify patients who are at the highest risk of CKD progression. The identification of patients who are at high risk, in turn, can inform treatment intensification and referral to nephrology care. However, more than 10 years since its introduction,6Tangri N. Stevens L.A. Griffith J. et al.A predictive model for progression of chronic kidney disease to kidney failure.JAMA. 2011; 305: 1553-1559Crossref PubMed Scopus (666) Google Scholar the use of the KFRE remains low among primary care providers who care for the lion’s share of patients with CKD. The lack of KFRE’s integration into electronic health record (EHR) systems has been cited as one of the major barriers to its systemic adoption. As reported in this issue of Kidney Medicine, Samal et al7Samal L. D’Amore J.D. Gannon M.P. et al.Impact of kidney failure risk prediction clinical decision support on monitoring and referral in primary care management of CKD: a randomized pragmatic clinical trial.Kidney Med. 2022; 4: 100493Abstract Full Text Full Text PDF Scopus (1) Google Scholar conducted a nonblinded, pragmatic clinical trial of a noninterruptive clinical decision support (CDS) tool within a primary care network of 11 clinics in the greater Boston area to determine whether embedding the KFRE within the EHR can improve CKD-related laboratory testing and referral of patients who are at high risk to nephrology. Patients assigned to each primary care provider were block randomized either to have the CDS banner displayed on their EHR 2 days before their primary care visit or to undergo usual care. The EHR-based CDS banner reported the patient’s 5-year risk of kidney failure on the basis of the 4-variable KFRE, comprising age, sex, urine albumin-to-creatinine ratio, and estimated glomerular filtration rate.5Tangri N. Grams M.E. Levey A.S. et al.Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis.JAMA. 2016; 315: 164-174Crossref PubMed Scopus (273) Google Scholar The notification also included an embedded hyperlink for a more detailed review of relevant laboratory data for KFRE calculation. Among patients with an estimated 5-year risk of >10%, recommendations for laboratory testing and nephrology referral were displayed. For those missing KFRE data elements, low and high values were substituted to report a range of risk. For patients assigned to the intervention group, the CDS output was displayed at several visits during the 12-month intervention period. Outcomes were ascertained 6 months after a primary care visit and included completion of the laboratory tests needed for the 8-variable KFRE calculation (ie, additionally includes serum albumin, bicarbonate, phosphorus, and calcium) as the primary outcome. Secondary outcomes included urine albumin-to-creatinine ratio testing among patients who were not tested in the preceding 12 months and nephrology referral among those with an estimated 5-year risk of >10%. In total, 2,794 and 2,796 patients were randomized to the intervention and control arms, respectively. At enrollment, the minority of patients in both arms had all the laboratory findings needed to calculate their kidney failure risk by the 4-variable KFRE. As observed consistently in the United States, only one-third had undergone urine albumin-to-creatinine ratio testing; this proportion is slightly lower than the overall national percentage of urine protein testing among persons with CKD in the United States.8United States Renal Data System2021 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2021https://adr.usrds.org/2021Date accessed: May 17, 2022Google Scholar Consequently, for most patients in the intervention arm, the CDS tool presented a range of kidney failure risks using 2 possible values for each missing laboratory finding. During the course of the study, fewer than half of the 139 primary care providers to whom the kidney failure risk was displayed clicked on the embedded hyperlink and only 10% clicked on the hyperlink more than once. At 6 months, the proportion of patients who had undergone additional recommended laboratory testing was similar between the randomization groups. Among those with a 5-year kidney failure risk of >10% (n = 840), paradoxically, fewer patients in the intervention arm, compared with the control arm, were referred to nephrology (28% vs 38%, respectively). As is imperative in pragmatic trials, the investigators obtained early input on the CDS tool from the target end users and enlisted a local clinical champion.9Eichner J. Das M. Challenges and Barriers to Clinical Decision Support (CDS) Design and Implementation Experienced in the Agency for Healthcare Research and Quality CDS Demonstrations. Agency for Healthcare Research and Quality; 2010.https://digital.ahrq.gov/sites/default/files/docs/page/CDS_challenges_and_barriers.pdfGoogle Scholar However, this study also encountered challenges that are common to CDS implementation. First, whether the investigators and the primary care practices established shared prioritization of improving CKD care is unclear; primary care providers often contend with multiple medical issues in a single clinic visit, and CKD is relatively deprioritized compared to diabetes and hypertension.3Sperati C.J. Soman S. Agrawal V. et al.Primary care physicians’ perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study.PLoS One. 2019; 14e0221325Crossref PubMed Scopus (22) Google Scholar Second, although the CDS display was noninterruptive, prior studies indicate that both repeated alerts and a higher volume of alerts can increase alert fatigue.10Ancker J.S. Edwards A. Nosal S. et al.Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system.BMC Med Inform Decis Mak. 2017; 17: 36Crossref PubMed Scopus (188) Google Scholar Third, the informational presentations on the CDS tool were likely insufficient to overcome the primary care providers’ unfamiliarity with the KFRE. Moreover, the low rates of urine albumin-to-creatinine ratio testing led to the majority of patients having a range of risks displayed, and the lack of familiarity and comfort with interpreting the KFRE results may have led providers to ignore them. Although prospective implementation studies and trials are ongoing,11Harasemiw O. Drummond N. Singer A. et al.Integrating risk-based care for patients with chronic kidney disease in the community: study protocol for a cluster randomized trial.Can J Kidney Health Dis. 2019; 62054358119841611Crossref PubMed Scopus (10) Google Scholar,12Hemmelgarn B.R. Smekal M.D. Weaver R.G. et al.Implementation and evaluation of a risk-based approach to guide chronic

Abstract licence: CC BY-NC-ND

References15

  1. 4.

14 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.